ST
Shattuck Labs, Inc.
STTK · NASDAQ
$6.79 -0.73% (-$0.05)
1M -6.60%
Market Cap $629.0M
P/E Ratio -
Div. Yield -
ROE 43.57%
Piotroski F-Score Weak
2/9Valuation
34 /100
Fair P/B 2.98x
P/S 628.99x
EV/EBITDA N/A
Growth
69 /100
Growing Book val. growth 22.38%
Rev. growth 15.32%
FCF growth N/A
Profitability
0 /100
Weak Net margin 5,256.80%
Op. margin 5,578.70%
FCF margin 4,124.00%
Quality
0 /100
Poor ROE 43.57%
ROA 23.82%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 27.59x
Debt/Equity 0.01x
Net debt/EBITDA N/A
Stability
46 /100
Moderate Rev. volatility 169.19%
EPS volatility 19.43%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about STTK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Taylor H. Schreiber
Employees
40
Headquarters
Austin
Upcoming events
10 NOV
Earnings
Upcoming earnings report